DE EN Anmelden

In your studies 'Drug Regulator Affairs'

©Volker Lannert / Universität Bonn

Master's thesis


As part of the continuing education Master's degree programme, Master's theses are written on relevant topics in the field of 'Drug Regulatory Affairs' using scientific methods. The topics are highly topical, diverse and the results are both of interest in a scientific context and relevant to many areas of activity in 'Drug Regulatory Affairs'.

Here you will find all Master's theses written since the year 2000, including the title and a summary. In this collection, many Master's theses can also be viewed and downloaded in full text.

Further information on Master's theses (e.g. registration, processing) can be found in our ‘Master's thesis guidelines/Leitfaden für die Anfertigung einer Masterarbeit’ (in German) and in the ‘Information leaflet - Master's thesis’ at

Downloads from A-Z

Do you have any questions or are you interested in the full text of a Master's thesis that is not listed here?
Please feel free to contact me.

Dr. Jasmin Fahnenstich

Dr. Jasmin Fahnenstich

Study programme manager

Phone: +49 (0) 228 - 9268 6806

Send e-mail

Master's thesis

The collection of Master's theses can be searched and sorted by entering keywords.

Year Name Title Full text Summary
2015 Stephan Hurtmanns European Union Article 31 referral procedures: a case study on the example of GVK Biosciences
2015 Katharina Illgen Non-human primates in research and safety testing
2015 Muhammad Zahid Iqbal The application of the quality by design approach for the analytical method development in the pharmaceutical industry
2015 Dr. Helene Kern How to develop a fictitious combined ATMP regarding non-clinical and early clinical phase: A possible SME Scenario ***
2015 Dr. Iris Krugmann The Role of Alcohol in Pharmaceutical Products ***
2015 Lucille Küng Phytopharmaceuticals: Analysis of the authorised landscape in the EU and resulting submission opportunities and challenges from the view of a SME ***
2015 Lisa Kunzmann Interactions between Regulatory Affairs and Pharmacovigilance
2015 Dr. Christa Lamping The Applicability of Scientific Guidelines to Allergens of Biological and Biotechnological Origin - A User Manual ***
2015 Celine Lentrodt The new European Pharmacovigilance Legislation and its impact on the Generics Industry
2015 Dr. Elke Maneke Article 45 EU Worksharing Procedure conducted according to Paediatric Regulation (EC) 1901/2006: What has been accomplished for paediatric use? – A Retrospective Analysis ***
2015 Markus Meinhard The International Generic Drug Regulator Pilot (IGDRP) - A new approach to increase effectiveness in the field of marketing authorisations for generic medicines
2015 Dr. Maike Melullis Best practice of worldwide product variations regarding planning, conduct and implementation ***
2015 Dr. Madeleine Meusburger Die Zulassung von Arzneimitteln im Schweizer Heilmittelgesetz und seine Revision – ein Vergleich mit dem deutschen Arzneimittelgesetz ***
2015 Caroline Mohr Plant made pharmaceuticals (PMPs) as medicinal products for human use - a review of current regulatory issues and challenges to achieve a marketing authorisation in the EU ***
2015 Dr. Katrin Motejlek Pharmacodynamic data submitted for the marketing authorization of biopharmaceuticals in the European Union ***
2015 Anke Müller Regulatory requirements for Transdermal Drug Delivery Systems - A step forward to feasibility and harmonisation?
2015 Annette Mutschler Environmental risk requirements for human medicinal products in the EU: an outlook from an industries' perspective
2015 Dr. Olga Neumüller Factor VIII Concentrates and the AMNOG Early Benefit Assessment - Case Study Turoctocog alfa and Simoctocog alfa ***
2015 Sven Nisius Setting up a Regulatory Intelligence function - A thorough discussion on the process to initiate, develop, implement and maintain a trusted source of regulatory information
2015 Barbara Petri Aesthetic indications: How to bring aesthetic medicinal products to the market?
  • Total: 959